Posts by Kristen E. Burke, MD
-
Immunosuppressive Therapy for IBD Not Linked to Increased Risk of COVID-19
Kristen E. Burke, MD, MPH, Bharati Kochar, MD and Ashwin N. Ananthakrishnan, MD, MPH, of the Crohn's and Colitis Center, and colleagues collected reassuring data that patients with inflammatory bowel disease can continue using immunosuppressive medication during the COVID-19 pandemic.
-
Incorporating Advanced Practice Providers into GI Practice
Andrea H. Thurler, DNP, Kyle Staller, MD, MPH, and Kristin E. Burke, MD, MPH, give pointers on how—and why—to integrate a nurse practitioner or physician assistant into a gastroenterology practice.
-
Patients with Microscopic Colitis Are at Increased Risk of Inflammatory Bowel Disease
Based on histologic data and more than 20 years of follow-up, a nationwide registry study has demonstrated that patients with microscopic colitis are substantially more likely than those without to develop inflammatory bowel disease.
-
Hormone Replacement Therapy, Oral Contraceptives May Increase Risk of Microscopic Colitis
There's a new reason for women to minimize the use of menopausal hormone replacement therapy: Massachusetts General Hospital gastroenterologists have demonstrated an association between exogenous estrogen and the risk of microscopic colitis.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.